Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Francis Cano | M | 79 | 15 years | |
| Dan Kisner | M | 77 | 14 years | |
| Julia Eastland | F | 59 | 4 years | |
| Robert Janssen | M | 70 | 14 years | |
| David Novack | M | 62 | 11 years | |
| Brent MacGregor | M | 60 | 4 years | |
| Peter Paradiso | M | 73 | 4 years | |
| Meg Smith | F | - | 5 years | |
| Peter Davis | M | 79 |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 26 years |
| Jeff P. Coon | M | 61 | 5 years | |
| Justin Burgess | M | - | 12 years | |
| Dong Yu | M | - | 3 years | |
| Riccardo Manetti | M | - | 4 years | |
| Todd Lopeman | M | - | 10 years | |
| Patricia Novy | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joel A. Fernandes | M | 54 |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | - |
| Arnold Lewis Oronsky | M | 83 | 24 years | |
| Hollings Renton | M | 77 |
Cetus Corp.
| 8 years |
| Andrew Hack | M | 50 | 4 years | |
| Steven N. Gersten | M | - | - | |
| Dennis A. Carson | M | 77 | 24 years | |
| J. Tyler Martin | M | 64 | 4 years | |
| Stanley Plotkin | M | 92 | 13 years | |
| Laura Brege | F | 66 | 5 years | |
| Jennifer Lew | F | 51 | 9 years | |
| Kris F. Heinzelman | M | - |
Brown University
| - |
| Stephen F. Tuck | M | 62 | 10 years | |
| Dino Dina | M | 77 | 17 years | |
| Stephanie Wong | F | 50 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 7 years |
| Deborah A. Smeltzer | F | 70 | 4 years | |
| Robert A. Fildes | M | 85 |
Cetus Corp.
| - |
| Eddie J. Gray | M | 64 | 6 years | |
| Wook-Hyun Kwon | M | 81 |
Brown University
| 3 years |
| Gregory Lloyd | M | - |
Brown University
| 6 years |
| Robert P. Allen | M | - |
Brown University
| 4 years |
| Timothy G. Henn | M | 66 | 3 years | |
| Bruce Cozadd | M | 60 |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | 12 years |
| Denise M. Gilbert | M | 66 | 11 years | |
| David Burke | M | - | 1 years | |
| John V. Guttag | M | 75 |
Brown University
| 4 years |
| Nat Ricciardi | M | 75 | - | |
| Craig C. Taylor | M | 74 |
Brown University
| 6 years |
| Dick Wingate | M | 71 |
Brown University
| 4 years |
| Bruce Douglas Moore | M | 75 |
Brown University
| 4 years |
| Nilene R. Evans | F | - |
Brown University
| 4 years |
| Alan Wovsaniker | M | - |
Brown University
| 4 years |
| Thomas I. Acosta | M | 74 |
Brown University
| 4 years |
| Willis J. Goldsmith | M | - |
Brown University
| 4 years |
| Barbara G. Ryder | M | - |
Brown University
| 4 years |
| Michael C. Nichols | M | 70 |
Brown University
| 4 years |
| Harold Reader | M | - |
Brown University
| 4 years |
| Sandy MacFarlane | M | 69 |
Brown University
| 4 years |
| John Joseph Anton | M | - |
Brown University
| 3 years |
| William Carr | M | - |
Brown University
| 4 years |
| Gregory R. Hill | M | 71 |
Brown University
| 4 years |
| Stacy Nerenstone | M | - |
Brown University
| 4 years |
| Richard Jaffee | M | - |
Brown University
| 6 years |
| Thomas A. Hart | M | - |
Brown University
| 4 years |
| Marc Stuart Freed | M | - |
Brown University
| 5 years |
| Eduardo Montealegre Rivas | M | 69 |
Brown University
| 4 years |
| Kenneth Winston Starr | M | - |
Brown University
| 1 years |
| Mary Vascellaro | F | - |
Brown University
| 4 years |
| Brooke Peterson | M | 74 |
Brown University
| 4 years |
| Mike Sherman | M | - |
Brown University
| 4 years |
| Roger Henry Ingwersen | M | - |
Brown University
| 3 years |
| Sylvia Leigh Ferst | F | - |
Brown University
| 5 years |
| John Ferring | M | - |
Brown University
| 4 years |
| Alan West | M | - |
Brown University
| 4 years |
| James Tracy Colby | M | - |
Brown University
| 4 years |
| Brian Stark | M | 69 |
Brown University
| 4 years |
| Paul H. Litwack | M | 67 |
Brown University
| 4 years |
| Craig Foster Heimark | M | 70 |
Brown University
| 5 years |
| Anthony Riley | M | 57 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 1 years |
| John J. Gorman | M | 68 |
Brown University
| 4 years |
| John G. Perenchio | M | 68 |
Brown University
| 4 years |
| Deborah A. Coleman | M | 71 |
Brown University
| 4 years |
| Duncan M. Davidson | M | 71 |
Brown University
| 4 years |
| Craig Jacobson | M | 71 |
Brown University
| 4 years |
| Graham Yoshio Tanaka | M | - |
Brown University
| 4 years |
| Henry Ketcham | M | 74 |
Brown University
| 4 years |
| Steven Rattner | M | 71 |
Brown University
| 4 years |
| David Abbott Tillson | M | - |
Brown University
| 4 years |
| John J. Bonacum | M | - |
Brown University
| 4 years |
| Richard Steere Aldrich | M | - |
Brown University
| 4 years |
| Robert B. Zink | M | - |
Brown University
| 4 years |
| Frank A. Bellis | M | 70 |
Brown University
| 4 years |
| Barry A. Schub | M | - |
Brown University
| 4 years |
| Fla Lewis | M | 71 |
Brown University
| 4 years |
| Gerald D. Cohen | M | 70 |
Brown University
| 4 years |
| Stephen M. Souza | M | 71 |
Brown University
| 4 years |
| Jeffrey P. Gilbard | M | - |
Brown University
| 4 years |
| David L. Wasserman | M | 70 |
Brown University
| 4 years |
| Jeffrey Tabak | M | - |
Brown University
| 4 years |
| Robert V. Gilbane | M | - |
Brown University
| 4 years |
| George Barrett | M | 69 |
Brown University
| 4 years |
| Larry Elder | M | - |
Brown University
| 4 years |
| George F. White | M | - |
Brown University
| 4 years |
| Daniel Rowen | M | - |
Brown University
| 4 years |
| Bruce Pitt | M | - |
Brown University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael S. Ostrach
- Personal Network
